BETASERON COULD COST MEDICAID/MEDICARE ABOUT $200 MIL. PER YEAR, SEN. PRYOR PROJECTS; ASKS BERLEX TO CONSIDER LARGE UNAPPROVED USE MARKET IN SETTING PRICE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".